Abstract:Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial. The objective of this research was to employ efficient biomarkers for the diagnostic analysis and classification of AD based on combining structural MRI (sMRI) and resting-state functional MRI (rs-fMRI). So far, several anatomical MRI imaging markers for AD diagnosis have been identified. The use of cortical and subcortical volumes, the hippocampus, and amygdala volume, as well as genetic patterns, has proven to be beneficial in distinguishing patients with AD from the healthy population. The fMRI time series data have the potential for specific numerical information as well as dynamic temporal information. Voxel and graphical analyses have gained popularity for analyzing neurodegenerative diseases, such as Alzheimer's and its prodromal phase, mild cognitive impairment (MCI). So far, these approaches have been utilized separately for the diagnosis of AD. In recent studies, the classification of cases of MCI into those that are not converted for a certain period as stable MCI (MCIs) and those that converted to AD as MCIc has been less commonly reported with inconsistent results. In this study, we verified and validated the potency of a proposed diagnostic framework to identify AD and differentiate MCIs from MCIc by utilizing the efficient biomarkers obtained from sMRI, along with functional brain networks of the frequency range .01-.027 at the resting state and the voxel-based features. The latter mainly included default mode networks (amplitude of low-frequency fluctuation [ALFF], fractional ALFF [ALFF], and regional homogeneity [ReHo]), degree centrality (DC), and salience networks (SN). Pearson's correlation coefficient for measuring fMRI functional networks has proven to be an efficient means for disease diagnosis. We applied the graph theory to calculate nodal features (nodal degree [ND], nodal path length [NL], and between centrality [BC]) as a graphical feature and analyzed the connectivity link between different brain regions. We extracted three-dimensional (3D) patterns to calculate regional coherence and then implement a univariate statistical t-test to access a 3D mask that preserves voxels showing significant changes. Similarly, from sMRI, we calculated the hippocampal subfield and amygdala nuclei volume using Freesurfer (version 6). Finally, we implemented and compared the different feature selection algorithms to integrate the structural features, brain networks, and voxel features to optimize the diagnostic identifications of AD using support vector machine (SVM) classifiers. We also compared the performance of SVM with Random Forest (RF) classifiers. The obtained results demonstrated the potency of our framework, wherein a combination of the hippocampal subfield, the amygdala volume, and brain networks with multiple measures of rs-fMRI could significantly enhance the accuracy of other approaches in diagnosing AD. The accuracy obtained by the proposed method was reported for binary classification. More importantly, the classification results of the less commonly reported MCIs vs. MCIc improved significantly. However, this research involved only the AD Neuroimaging Initiative (ADNI) cohort to focus on the diagnosis of AD advancement by integrating sMRI and fMRI. Hence, the study's primary disadvantage is its small sample size. In this case, the dataset we utilized did not fully reflect the whole population. As a result, we cannot guarantee that our findings will be applicable to other populations.

The Identification of Alzheimer’s Disease Using Functional Connectivity Between Activity Voxels in Resting-State fMRI Data

Alzheimer's Disease Early Diagnosis Based on Resting-State Dynamic Functional Connectivity

Classification of Alzheimer’s Disease Based on Abnormal Hippocampal Functional Connectivity and Machine Learning

Classification of Alzheimer's Disease Based on Abnormal Hippocampal Functional Connectivity and Machine Learning

Intrinsic Functional Component Analysis Via Sparse Representation on Alzheimer's Disease Neuroimaging Initiative Database.

A Study Of Feature Extraction For Alzheimer'S Disease Based On Resting-State Fmri

Disrupted Regional Cerebral Blood Flow, Functional Activity and Connectivity in Alzheimer’s Disease: A Combined ASL Perfusion and Resting State fMRI Study

Functional Brain Network Measures for Alzheimer's Disease Classification

Disrupted Regional Cerebral Blood Flow, Functional Activity and Connectivity in Alzheimer's Disease: A Combined ASL Perfusion and Resting State Fmri Study.

Individual Identification for Different Age Groups Using Functional Connectivity Strength

Alzheimer's Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI

Temporal and Spatial Analysis of Alzheimer’s Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network

Grab‐AD: Generalizability and Reproducibility of Altered Brain Activity and Diagnostic Classification in Alzheimer's Disease

Dynamic Functional Connectivity and Graph Convolution Network for Alzheimer's Disease Classification

ABNORMAL BRAIN CONNECTIVITY DYNAMICS AND BRAIN ACTIVITY STATES IN ALZHEIMER’S DISEASE

Detection of Alzheimer’s Disease Using Dynamic Functional Connectivity Patterns in Resting-State fMRI

Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI

Preclinical Stages Of Alzheimer'S Disease Classification By A Rs-Fmri Study

Resting-State Brain Network Dysfunction Characteristic of Alzheimer’s Disease

Biomarkers Derived from Alterations in Overlapping Community Structure of Resting-state Brain Functional Networks for Detecting Alzheimer’s Disease

Identification of Alzheimer's Disease Progression Stages Using Topological Measures of Resting-State Functional Connectivity Networks: A Comparative Study